Stoke Therapeutics(STOK)
Focus: Stoke Therapeutics is a public biotech company specializing in antisense oligonucleotide medicines for gene therapy indications, with a focus on rare neurological and genetic diseases. The company is headquartered in Bedford, MA and operates as a clinical-stage organization with multiple programs in development.
Profile data last refreshed 6h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
26+12 this month
Growing — net +12 jobs in 30d
17 jobs added vs 5 removed. Steady team buildout.
Should You Work at Stoke Therapeutics?
AI assessmentStoke is a high-risk, high-reward clinical-stage biotech entering commercialization phase; ideal for candidates seeking rare-disease impact with tolerance for biotech volatility.
Why Work Here
- Lead-stage programs in rare neurological diseases (Dravet Syndrome Phase 3) with clear regulatory pathways and meaningful patient impact
- Aggressive hiring across regulatory, clinical, manufacturing, and support functions signals confidence in pipeline advancement and commercial preparation
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$37M
Pipeline & Clinical Trials
Experimental: Device Intervention
Spinal Cord InjuriesClinical Trials (1)
NCT05615766Assessment of a Robotic Exoskeleton for Upper Limb Rehabilitation
N/AHelp build intelligence for Stoke Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.